Clinical-stage biotech company developing medicines for rare diseases using chemoproteomics platform to target previously untreatable conditions.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Jnana Therapeutics is a clinical-stage biotechnology company using its RAPID chemoproteomics platform to develop medicines for challenging drug targets in diseases with high unmet needs. The company focuses on creating first- and best-in-class therapies for rare and immune-mediated diseases. Its lead program, JNT-517, targets an allosteric site on SLC6A19, offering a potential first-in-class oral treatment for phenylketonuria (PKU), a rare metabolic disorder.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Jnana Therapeutics Management Team
Investors
Polaris Partners
Pfizer
RA Capital Management
Versant Ventures
AbbVie Ventures
Bain Capital
Avalon Ventures
Jnana Therapeutics Valuations & Financials
View real-time NPM data on Jnana Therapeutics stock including most recent valuation and historical share price information. Are you an institutional investor or employee shareholder? Sign up to the SecondMarket trading platform.
Similar Companies
like Jnana Therapeutics
Cerebral
Health Care
Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.
Virta Health
Health Care
Online specialty medical clinic focused on reversing type 2 diabetes.
Color Genomics
Health Care
Physician-ordered genetic testing with comprehensive support, utilizing advanced software and a certified laboratory.
Somatus
Health Care
Integrated care for patients with or at risk of developing kidney disease.
Tonal
Health Care
Delivers AI-powered strength training with digital weights and personalized coaching.
Devoted
Health Care
Provides Medicare Advantage plans to improve older Americans' well-being with comprehensive and family-oriented care.
FAQ
We have answers
Jnana Therapeutics stock does not trade on public stock exchanges. Jnana Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Jnana Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Jnana Therapeutics Stock does not trade on public stock exchanges. In order to sell Jnana Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Jnana Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Jnana Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Jnana Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Jnana Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Jnana Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Jnana Therapeutics is a private company and has not had an IPO. There is currently no Jnana Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Jnana Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
